Given the crisis, I often wonder why the FDA did n

Given the crisis, I often wonder why the FDA did not appoint a committee to review the data on a rolling basis as the covid trials were underway, and assist the promising ones through funding or larger trials etc. It really wasn't that hard to keep an eye on the prospects. I know I reviewed them all before deciding to invest more in Cytodyn.